Long Focus Capital Management, LLC Iovance Biotherapeutics, Inc. Put Options Transaction History
Long Focus Capital Management, LLC
- $2.17 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IOVA
# of Institutions
287Shares Held
233MCall Options Held
1.12MPut Options Held
1.15M-
Mhr Fund Management LLC New York, NY29MShares$65.8 Million8.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA25.1MShares$56.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$48.2 Million0.0% of portfolio
-
State Street Corp Boston, MA9.89MShares$22.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny9.33MShares$21.2 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $358M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...